Simple Summary Cancer mortalities are growing at an alarming pace around the globe, a
fact related to challenges, such as side effects, selectivity, and resistance, accompanied by …

The survival rates of many cancers have significantly improved due to recent advancements
in cancer screening and therapeutics. Although better cancer outcomes are encouraging …

Context Androgen receptor signaling inhibitor (ARSi) agents are emerging as standard
treatments for prostate cancer across the disease spectrum, but much remains unknown …

Opinion statement With improvements in treatment and survival from prostate cancer,
comorbid cardiac conditions will significantly impact overall morbidity and mortality from …

Clinical data has shown that cardiovascular diseases (CVDs) have emerged as a prominent
cause of mortality in individuals with hepatocellular carcinoma (HCC). This research aimed …

Hypertension is one of the most common comorbidity and the leading cause of cancer-
related death in cancer patients. The prevalence of hypertension in cancer patients is much …

Oncohypertension is a relatively recent concept that refers to the development of elevated
blood pressure in patients with cancer, which is driven by the tumor itself. This review article …

Background: Cancer, hypertension, and kidney disease are closely interrelated. Knowledge
of the inadvertent hypertensive and nephrotoxic effects of antineoplastic medications is …